Neuroblastoma

Childhood Tumour Surgery › Neuroblastoma

Neuroblastoma in Children: Diagnosis, Risk Groups and the Role of Surgery

Medically reviewed by Dr. Koushik Herle, MCh, DNB (Paediatric Surgery), Consultant Pediatric Surgeon and Pediatric Urologist, on 3 November 2026

Your young child has a swollen tummy. Or a limp that will not go away. Or dark bruising around the eyes, without any history of a fall. The ultrasound or CT scan shows a mass near the kidney. The word your doctor uses is neuroblastoma.

Neuroblastoma is a tumour of developing nerve tissue. It most often starts in the adrenal gland, which sits just above the kidney. Because it grows from early nerve cells (the sympathetic nervous system), it can also arise along the spine, in the tummy, chest, neck or pelvis.

It is one of the most common solid tumours of early childhood and is usually found before a child turns 5. Here is the part many families do not expect: neuroblastoma behaves very differently from child to child. Some tumours in babies shrink and disappear on their own without treatment. Others need intensive, combined treatment. Finding out which kind of tumour your child has is the first and most important step.

Key points for parents

  • Neuroblastoma is a tumour of developing nerve tissue, most often in the adrenal gland above the kidney.
  • It behaves very differently from child to child. Some tumours in babies shrink on their own.
  • Treatment is planned by risk group, which depends on age, stage and the tumour’s biology (such as MYCN).
  • The biopsy matters. It is done to measure the tumour’s biology as well as to name it.
  • Surgery is one part of a larger plan. It is often done after chemotherapy has shrunk the tumour.
  • A pediatric oncologist and a pediatric surgeon should treat your child together.

Signs parents notice

Symptoms depend on where the tumour is growing and whether it has spread:

  • A firm lump or swelling in the tummy.
  • Bone pain, a sudden limp or extreme irritability.
  • Dark bruising or swelling around the eyes (often called “raccoon eyes”).
  • Persistent fever, tiredness, paleness (anaemia) or weight loss.
  • A lump in the neck, or a drooping eyelid with a small pupil on one side (Horner syndrome).
  • Rarely, rapid, jerky eye and body movements (opsoclonus-myoclonus syndrome).

Do not wait. Take your child to the nearest emergency hospital if a child with a known or suspected tumour develops weakness in the legs, severe back pain with difficulty walking, inability to pass urine or stool, or sudden difficulty breathing. These can mean the tumour is pressing on the spinal cord or the airway, which is a medical emergency.

Diagnosis: more than imaging

An ultrasound is usually the first test. A CT or MRI scan then shows the tumour and how it relates to the major blood vessels and the spine.

Neuroblastoma cells often release specific chemicals. A urine test for catecholamines (VMA and HVA) helps confirm the diagnosis. An MIBG scan, a nuclear medicine scan that about 90% of neuroblastomas take up, and a bone marrow test look for spread of the disease.

Why the biopsy matters

If the scans and urine tests point to neuroblastoma, a biopsy is usually needed. It is not only to name the tumour. Its most important job is to measure the tumour’s biology, above all whether the MYCN gene has extra copies (amplification). Tumours with MYCN amplification behave more aggressively.

This biological profile decides how intensive treatment needs to be. Where possible, the biopsy is taken by keyhole surgery (laparoscopy or thoracoscopy) or under image guidance, such as a CT-guided core biopsy.

Risk groups (COG and INRG)

Treatment is not planned by stage alone. It is planned by risk group, worked out from the child’s age, the extent of the tumour (stage) and its biology, including MYCN status. Paediatric oncology teams use frameworks such as the Children’s Oncology Group (COG) and the International Neuroblastoma Risk Group (INRG).

  • Low-risk tumours: often need surgery alone. In some young infants, including those with “stage 4S” or “MS” disease that has spread only to the skin, liver or bone marrow, careful observation may be enough, because these tumours can shrink on their own.
  • Intermediate-risk tumours: usually need moderate chemotherapy to shrink the tumour, followed by surgery.
  • High-risk tumours: need intensive combined treatment: chemotherapy, surgery, high-dose chemotherapy with stem cell rescue (transplant), radiotherapy and newer immunotherapy.

A related tumour, ganglioneuroma, is benign and fully matured. It does not spread and is treated by surgical removal alone.

The role of surgery

Surgery is one specific part of a larger, coordinated plan. Neuroblastoma often wraps around major blood vessels such as the aorta and vena cava, so the surgery has to serve the overall plan and not the other way round.

  • The right biopsy first, to secure the biological diagnosis.
  • The right timing for removal. Often the operation waits until chemotherapy has shrunk the tumour and loosened its hold on the blood vessels, which can make the operation safer.
  • An operation that removes what is safe to remove, while protecting the kidneys, the major blood vessels and the nearby nerves.

Every surgical decision is made together with the pediatric oncologist and the family.

Frequently asked questions

Can neuroblastoma really go away on its own?

In some babies, yes. Certain low-risk neuroblastomas, especially in infants under about 12 to 18 months, can mature into benign tissue or shrink and disappear without treatment. These children are watched closely with scans and tests, and treated only if the tumour grows or causes problems.

Does every child with neuroblastoma need chemotherapy?

No. Some low-risk tumours are treated with surgery alone or with careful observation. The need for chemotherapy depends on the child’s risk group.

Why is the operation sometimes done after chemotherapy?

Neuroblastoma often entangles important blood vessels. Chemotherapy can shrink the tumour and pull it away from these vessels. Operating after that can make the surgery safer and allow a more complete removal.

Who should treat my child?

A pediatric oncologist and a pediatric surgeon, working together. Risk grouping and children’s tumour protocols are complex, so treatment should be planned by a dedicated multidisciplinary pediatric oncology team, with a pediatric oncology centre supporting high-risk treatment.

Questions you may want to ask at your visit

  • What is my child’s risk group, and what does it mean for treatment?
  • Has the tumour been tested for MYCN and other features?
  • Is observation an option for this child?
  • Will surgery come before or after chemotherapy?
  • Which specialists will treat my child?

Consult your pediatric surgeon early to understand your options. Understanding your child’s risk group is the first step to the right plan.

For more on navigating a childhood cancer diagnosis, you may also wish to read the parents’ guide to Wilms tumour (kidney cancer).

Related pages

References

  1. National Cancer Institute. Neuroblastoma Treatment (PDQ), patient version.

Clinic location

  • Manipal Hospital, Electronic City, Bengaluru.

Appointments: +91 8217553785

This page is educational information and is not a substitute for individual medical advice. Drafted with AI assistance and medically reviewed by Dr. Koushik Herle.

Quick Links

Book Appointment